| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP1000033B1 Heterocyclic derivatives which inhibit factor xa |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | EP0960106B1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 05/06/2004 | EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 05/06/2004 | EP0835115B1 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
| 05/06/2004 | EP0813409B1 Treatment of cytokine growth factor caused disorders |
| 05/06/2004 | CA2505597A1 Agent elevating dendritic cell precursor level in blood |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | CA2500848A1 Mitotic kinesin inhibitors |
| 05/06/2004 | CA2500836A1 Metal-containing materials, compositions and methods |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494551A Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494544A Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds |
| 05/05/2004 | CN1494526A Inhibitor of monoamine uptake |
| 05/05/2004 | CN1494435A Preparation for prophylaxis of restenosis |
| 05/05/2004 | CN1494429A Aguatic animal treatment method and composition containing pimenta extract |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494424A IL-8 receptor antagonists |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1493287A Shishan alkaloid drip pill and its preparation method |
| 05/05/2004 | CN1493270A Composition of component of skin whitening cosmetics |
| 05/05/2004 | CN1148447C Amino-terminally trancated RANTES as chemokine antagonists |
| 05/05/2004 | CN1148446C Polypeptide bound with MORT-1 and MACH and its DNA sequence, producing method, medical composition and use |
| 05/05/2004 | CN1148379C Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 05/05/2004 | CN1148372C Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha 1-blocking action |
| 05/05/2004 | CN1148369C 1,8-naphthyridine derivatives |
| 05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
| 05/05/2004 | CN1148360C Intermediate for preparing cascade polymeric ligand usable as contrast medium |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148356C Benzosulfone derivatives |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148349C N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
| 05/05/2004 | CN1148212C Injecta for promoting growth of pig |
| 05/05/2004 | CN1148207C Medicine for strengthening physique and resisting senility |
| 05/05/2004 | CN1148205C Medicine for treating perineum disease |
| 05/05/2004 | CN1148192C Cell-protecting amifostine and its preparing process |
| 05/05/2004 | CN1148189C Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors |
| 05/05/2004 | CN1148186C Clonidine preparation |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/05/2004 | CN1148181C Use of flavnolignanes for the prepn. of medicaments with antiproliferative activity in uterus, ovary and breast |
| 05/05/2004 | CN1148180C Compounds for treatment of estrogen-dependent illnesses and methods for making and using same |
| 05/05/2004 | CN1148173C Liniment for preventing pig bite |
| 05/04/2004 | US6730794 Substituted indolealkanoic acids |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730781 Using ceramic hydroxyapatite column chromatography; avoids toxic organic solvents and animal enzymes, centrifugations, tedious precipitation |
| 05/04/2004 | US6730778 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/04/2004 | US6730703 Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730687 Therapy of metabolic diseases such as diabetes and hyperlipidemia as agonists of peroxisome proliferator-activated receptor |
| 05/04/2004 | US6730683 Such as 1-cyclohexyl-4-(4-fluorophenyl)-5-((2-phenylamino)pyrimidin-4-yl)imidazole; for use as cytokine inhibitors |
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730674 Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 05/04/2004 | US6730671 Compounds useful as reversible inhibitors of cathespin S |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/04/2004 | US6730664 The side-effects of chemotherapy are suppressed or reduced |
| 05/04/2004 | US6730661 Non-digestible dextrans, hydrolysed (galacto)mannans and/or hydrolysed (gluco)mannans; reduce the uptake of high molecular weight substances, allergens and microorganisms through the intestinal wall |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730476 Methods of diagnosing early-onset menopause |
| 05/04/2004 | US6730332 Synergistic aqueous extract from fruits of terminalia chebula, bark of albizia lebbeck, terminalia bellerica and emblica officinalis |
| 05/04/2004 | US6730325 Multiparticulate modified release composition |
| 05/04/2004 | US6730324 Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 05/04/2004 | US6730319 Pharmaceutical compositions having depressed melting points |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2240296C Endothelial cell proliferation inhibitor and method of use |
| 05/04/2004 | CA2183234C Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
| 04/29/2004 | WO2004035594A1 Intermediate for producing carboxypeptidase b inhibitor |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035579A1 Imidazopyridine derivative, process for producing the same, and use |
| 04/29/2004 | WO2004035574A2 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands |
| 04/29/2004 | WO2004035572A1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n’-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/29/2004 | WO2004035093A2 Polymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004035089A1 Remedy for hormone-dependent cancer |
| 04/29/2004 | WO2004035085A1 Gene vaccine |
| 04/29/2004 | WO2004035065A1 Hypoglycemic substances containing zinc |
| 04/29/2004 | WO2004035053A1 Neurotrophic factor production promoter |
| 04/29/2004 | WO2004035048A1 Hepatic fibrosis inhibitor |
| 04/29/2004 | WO2004035038A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 04/29/2004 | WO2004035030A2 Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain |
| 04/29/2004 | WO2004035022A2 Prepolymeric materials for site specific delivery to the body |
| 04/29/2004 | WO2004019999A3 Agent delivery particle |